Obesity as a risk factor for antipsychotic noncompliance

Author： Weiden P.J. Mackell J.A. McDonnell D.D.

Publisher： Elsevier

ISSN： 0920-9964

Source： Schizophrenia Research, Vol.66, Iss.1, 2004-01, pp. : 51-57

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Antipsychotic drugs as a risk factor for venous thromboembolism

By Masopust Jirí Malý Radovan Urban Ales Hosák Ladislav Cermáková Eva

International Journal of Psychiatry in Clinical Practice, Vol. 11, Iss. 3, 2007-01 ,pp. : 246-249

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Non-compliance with anti-psychotic depot medication: Users' views on advantages and disadvantages

By Smith John A. Hughes Ian C. T. Budd Richard J.

Journal of Mental Health, Vol. 8, Iss. 3, 1999-06 ,pp. : 287-296

Informa Healthcare

Access to resources Recommend Favorite

Second-Generation Antipsychotic Medications and Risk of Pneumonia in Schizophrenia

By Kuo Chian-Jue Yang Shu-Yu Liao Ya-Tang Chen Wei J. Lee Wen-Chung Shau Wen-Yi Chang Yao-Tung Tsai Shang-Ying Chen Chiao-Chicy

Schizophrenia Bulletin, Vol. 39, Iss. 3, 2013-05 ,pp. : 648-657

Oxford University Press

Access to resources Recommend Favorite

Rational Antipsychotic Choice: Weighing the Risk of Tardive Dyskinesia and Metabolic Syndrome

By Stoklosa Joseph Öngür Dost

Harvard Review of Psychiatry, Vol. 19, Iss. 5, 2011-09 ,pp. : 271-276

Ashgate Publishing Ltd

Access to resources Recommend Favorite

The Influence of Study Design on the Results of Pharmacoepidemiologic Studies of Diabetes Risk With Antipsychotic Therapy

By Gianfrancesco Frank Wang Ruey-Hua Nasrallah Henry

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 18, Iss. 1, 2006-01 ,pp. : 9-17

Informa Healthcare

Access to resources Recommend Favorite